Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-011573
Filing Date
2017-10-13
Accepted
2017-10-13 14:18:10
Documents
42
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10k.htm 10-K 773627
2 ex31-1.htm EX-31.1 18125
3 ex31-2.htm EX-31.2 17988
4 ex32-1.htm EX-32.1 7735
5 ex32-2.htm EX-32.2 7636
  Complete submission text file 0001493152-17-011573.txt   1717182

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enzb-20170630.xml EX-101.INS 108553
7 XBRL SCHEMA FILE enzb-20170630.xsd EX-101.SCH 16151
8 XBRL CALCULATION FILE enzb-20170630_cal.xml EX-101.CAL 25842
9 XBRL DEFINITION FILE enzb-20170630_def.xml EX-101.DEF 40829
10 XBRL LABEL FILE enzb-20170630_lab.xml EX-101.LAB 105873
11 XBRL PRESENTATION FILE enzb-20170630_pre.xml EX-101.PRE 91858
Mailing Address 8440 W. LAKE MEAD SUITE 214 LAS VEGAS NV 89128
Business Address 8440 W. LAKE MEAD SUITE 214 LAS VEGAS NV 89128 702-907-0615
EnzymeBioSystems (Filer) CIK: 0001471968 (see all company filings)

EIN.: 270464302 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-53854 | Film No.: 171136329
SIC: 2834 Pharmaceutical Preparations